Skip to main content
Year archive

AROVELLA THERAPEUTICS LIMITED — 2020 filings

All 76 regulatory filings released by AROVELLA THERAPEUTICS LIMITED (ALA) in 2020, sourced directly from the official regulator.

76 Filings
2020 Period
2020 filings (76)
Filing Released Lang
Notice of EGM and Proxy form 18 pages 543.9KB
AGM Information
2020-12-23 English
Company Update - Letter to Shareholders 4 pages 202.0KB
Regulatory Filings
2020-12-21 English
Proposed issue of Securities - SUD 5 pages 27.7KB
Capital/Financing Update
2020-12-21 English
Placement Offer Completed and Appendix 2A 17 pages 434.0KB
Capital/Financing Update
2020-12-21 English
Ordesa Feasibility Study Update 2 pages 182.2KB
Regulatory Filings
2020-12-15 English
Placement Offer to raise $2.76m 3 pages 199.7KB
Capital/Financing Update
2020-12-15 English
Prospectus - Placement 36 pages 541.7KB
Capital/Financing Update
2020-12-15 English
Proposed issue of Securities - SUD 5 pages 28.0KB
Capital/Financing Update
2020-12-15 English
Proposed issue of Securities - SUD 5 pages 27.7KB
Capital/Financing Update
2020-12-15 English
Trading Halt 2 pages 346.0KB
Capital/Financing Update
2020-12-13 English
AGM FY20 Presentation 14 pages 1.2MB
AGM Information
2020-11-25 English
AGM FY20 Chairman's address and virtual meeting guide 8 pages 615.8KB
AGM Information
2020-11-25 English
Results of Annual General Meeting 2 pages 741.4KB
Declaration of Voting Results & Voting Rights Announcements
2020-11-25 English
SUD Constitution (amended) 53 pages 426.9KB
Governance Information
2020-11-25 English
R & D Tax Incentive refund received 2 pages 184.7KB
Capital/Financing Update
2020-11-23 English
Investor Presentation November 2020 15 pages 1.6MB
Investor Presentation
2020-11-16 English
Change of Director's Interest Notice - P. Hopper 2 pages 156.9KB
Director's Dealing
2020-11-10 English
Change of Director's Interest Notice - D.Simmonds 2 pages 156.3KB
Director's Dealing
2020-11-08 English
Change of Director's Interest Notice 2 pages 158.0KB
Director's Dealing
2020-10-27 English
Notice of General Meeting/Proxy Form 28 pages 738.6KB
AGM Information
2020-10-26 English
Quarterly Appendix 4C and Activities Report 8 pages 433.4KB
Interim / Quarterly Report Q1 2021
2020-10-25 English
Proposed issue of Securities - SUD 6 pages 29.5KB
Capital/Financing Update
2020-10-15 English
Appendix 2A 15 pages 435.4KB
Capital/Financing Update
2020-10-15 English
Newsletter October 2020 2 pages 182.0KB
Regulatory Filings
2020-10-07 English
Notice of 2020 Annual General Meeting 1 page 177.1K
AGM Information
2020-10-07 English
FY20 Annual Report to shareholders 88 pages 4.5MB
Annual Report FY 2020
2020-09-24 English
Appendix 4G and FY20 Corporate Governance Statement 24 pages 606.5KB
Regulatory Filings
2020-09-24 English
Anagrelide Project Update 5 pages 215.1KB
Capital/Financing Update
2020-09-21 English
Anagrelide Cancer Patent For Australia 2 pages 202.8KB
Regulatory Filings
2020-09-07 English
Preliminary Final Report 21 pages 317.6KB
Annual Report FY 2020
2020-08-30 English
Company Secretary 2 pages 183.4KB
Board/Management Information
2020-08-17 English
Placement Offer Completed and Appendix 2A 16 pages 483.2KB
Capital/Financing Update
2020-08-09 English
Change of Director's Interest Notice 3 pages 297.7KB
Director's Dealing
2020-08-06 English
Entitlement Offer Completed and Appendix 2A 16 pages 486.5KB
Capital/Financing Update
2020-08-04 English
Ceasing to be a substantial holder 2 pages 163.3KB
Major Shareholding Notification
2020-08-04 English
Top 20 securityholders 3 pages 192.2KB
Major Shareholding Notification
2020-08-04 English
Prospectus 38 pages 478.2KB
Capital/Financing Update
2020-08-04 English
Distribution of Security Holders 4 pages 205.5KB
Major Shareholding Notification
2020-08-04 English
Entitlement Offer Closes Significantly Oversubscribed 2 pages 197.5KB
Capital/Financing Update
2020-08-02 English
Becoming a substantial holder 2 pages 67.7KB
Major Shareholding Notification
2020-08-02 English
Proposed issue of Securities - SUD 5 pages 27.6KB
Capital/Financing Update
2020-08-02 English
Appendix 4C - quarterly 7 pages 383.1KB
Interim / Quarterly Report Q4 2020
2020-07-30 English
TGA Approval Granted For ZolpiMist 2 pages 197.6KB
Regulatory Filings
2020-07-28 English
Extension Of Offer Closing Date 3 pages 194.5KB
Capital/Financing Update
2020-07-15 English
Update - Proposed issue of Securities - SUD 9 pages 38.9KB
Capital/Financing Update
2020-07-15 English
Entitlement Offer To Raise Approximately $3.56 Million 4 pages 222.2KB
Capital/Financing Update
2020-07-02 English
Prospectus For Entitlement Offer 45 pages 585.0KB
Capital/Financing Update
2020-07-02 English
Proposed issue of Securities - SUD 9 pages 39.2KB
Capital/Financing Update
2020-07-02 English
Notice To Ineligible Shareholders 2 pages 185.5KB
Capital/Financing Update
2020-07-02 English
Notice To Eligible Shareholders 3 pages 192.1KB
Capital/Financing Update
2020-07-02 English
Notice To Option Holders 2 pages 148.0KB
Capital/Financing Update
2020-07-02 English
Investor Presentation 22 pages 1.5MB
Investor Presentation
2020-07-02 English
Initial Director's Interest Notice 2 pages 130.7KB
Director's Dealing
2020-07-02 English
Joint Company Secretary and Change of Registered Office 2 pages 180.3KB
Board/Management Information
2020-06-30 English
SUDA Appoints Dr Baker As Director 2 pages 181.2KB
Board/Management Information
2020-06-28 English
Market Update 2 pages 183.5KB
Capital/Financing Update
2020-06-24 English
Reinstatement to Official Quotation 1 page 217.7KB
Regulatory Filings
2020-06-24 English
Suspension from Official Quotation 2 pages 356.8KB
Regulatory Filings
2020-06-04 English
Pause in Trading 1 page 118.3KB
Regulatory Filings
2020-05-31 English
Trading Halt 2 pages 338.1KB
Capital/Financing Update
2020-05-31 English
Anagrelide Project Update 2 pages 194.0KB
Capital/Financing Update
2020-05-26 English
Anagrelide Cancer Patent For Japan 2 pages 189.1KB
Regulatory Filings
2020-05-19 English
ZolpiMist Update 2 pages 180.9KB
Capital/Financing Update
2020-05-11 English
Appendix 4C - quarterly 7 pages 413.5KB
Interim / Quarterly Report Q3 2020
2020-04-29 English
Letter To Shareholders 2 pages 286.5KB
Regulatory Filings
2020-03-30 English
ArTiMist Program On Hold 2 pages 182.2KB
Regulatory Filings
2020-03-29 English
SUDA Signs Additional Licence With Mitsubishi Tanabe 3 pages 207.0KB
Capital/Financing Update
2020-03-22 English
Interview With Michael Baker 1 page 175.8KB
Investor Presentation
2020-03-10 English
Investor Presentation 17 pages 1.3MB
Investor Presentation
2020-02-25 English
Half Yearly Report and Accounts 25 pages 613.0KB
Interim / Quarterly Report H1 2020
2020-02-25 English
Appendix 4C - quarterly 7 pages 427.9KB
Interim / Quarterly Report Q2 2020
2020-01-30 English
Interviews With Michael Baker 1 page 176.9KB
Regulatory Filings
2020-01-22 English
Newsletter January 2020 1 page 176.5KB
Regulatory Filings
2020-01-19 English
Interview With Michael Baker 2 pages 179.1KB
Regulatory Filings
2020-01-07 English
Appendix 3B 15 pages 618.0KB
Capital/Financing Update
2020-01-05 English
Change of Director's Interest Notice 3 pages 295.6KB
Director's Dealing
2020-01-05 English